Keywords
sacubitril,structural formula,Entresto,ahu-377,valsartan,arni,angiotensin receptor-neprilysin inhibitor,lcz696,c24h29no5,chemical structure,structural formula,ester group,carboxylic acid,amide bond,biphenyl group,phenyl rings,ethyl ester,methyl group,neprilysin inhibitor,prodrug,angiotensin receptor blocker,heart failure treatment,hypertension,raas,renin-angiotensin-aldosterone system,neprilysin inhibition,blood pressure regulation,cardiac function,natriuretic peptides,valsartan combination,prodrug converted to active lbq657,dual mechanism of action,synergy with valsartan,reduces cardiovascular mortality,carbon,hydrogen,nitrogen,oxygen,single bonds,double bonds,aromatic bonds,cardiovascular pharmacology,heart failure,hypertension medication,prodrug activation,cardioprotective agents,pharmaceutical chemistry,drug design,therapeutics,pharmacodynamics,pharmacokinetics,combination therapy,angiotensin receptor blocker,neprilysin enzyme,antihypertensive agents,cardiac function modulation,chronic heart failure,raas inhibitors,pharmacology,drug metabolism,pill,capsule,tablet,drug,medication,heart failure,carbon,c,oxygen,o,hydrogen,h,nitrogen,n,single bond,double bond,structural formula,structural,formula,chemical compound,structural chemistry,bond,line bond,charge,proj-creative-abx-24q2
proj-creative-abx-24q2,proj-creative-abx-24q2-novartis,sacubitril